Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 3.02% to $808.05 on Monday, outperforming the broader stock market which saw the S&P 500 Index and Dow Jones Industrial Average decline. This marks the fifth consecutive day of gains for the stock, despite a generally poor trading session for competitors.